Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, Republic of Korea
Disclosure information not submitted.
1A-05 - End-stage renal diseases associated with the use of SGLT2 inhibitors versus GLP-1 receptor agonists among individuals with metabolic dysfunction-associated steatotic liver disease: A nationwide cohort study
Sunday, August 24, 202511:30 AM - 11:45 AM ET
6C-05 - Aspirin use and the risk of hepatic events in patients with metabolic dysfunction-associated steatotic liver disease: A target trial emulation with clone-censor-weight approach
Tuesday, August 26, 20252:30 PM - 2:45 PM ET
